<?xml version="1.0" encoding="UTF-8"?>
<p>Mitigation and defeat of emerging infections have surfaced as the two major public-health approaches in controlling the virus (
 <xref rid="B16" ref-type="bibr">16</xref>). It is vital to reduce COVID-19 infection via minimizing human-to-human contact, which may, however, be publicly and economically unsustainable in the long term (
 <xref rid="B17" ref-type="bibr">17</xref>). A crucial infection control or preventive measure would include development of a vaccine. As of now, no licensed vaccine is available against this novel coronavirus, though quite a few are in various phases of clinical trial (
 <xref rid="B8" ref-type="bibr">8</xref>, 
 <xref rid="B9" ref-type="bibr">9</xref>).
</p>
